- Business Development
- Patient Reported Outcomes
- Clinical Trials
- Data Capture & Management
- Disease Strategy
- Drug Delivery
- eHealthcare
- Formulation
- Hit-to-Lead
- Partnering & Outsourcing
- Pharmacovigilance
- Preclinical
- Project & Risk Management
- Targets
- Technology Focus
- Translational & Personalized Medicine
- Trial Design & Protocols
- Virtual R&D
Specialties
11 June 2012
Latest Testimonial
"It has been a pleasure to be guest Editor-in-Chief for the inaugural issue of iHealth Connections which is being launched at...
Ric Day
Professor of Clinical Pharmacology
University of NSW
Disease Strategy
- GPR37/PAEL Receptor
- New Antiretroviral Drugs to Treat HIV/AIDS
- Endogenous Stem Cell Activation in the Brain
- Nasal Polyposis Treatment
GPR37/PAEL Receptor
The GPR37/PAEL Receptor – Finding a Way to the Cell Surface
Dutta Priyanka, Deb Debadutta , Dargahi Leila, Ivankovic Davor , Dev Kumlesh K
Drug Discovery, 2010
New Antiretroviral Drugs to Treat HIV/AIDS
Challenges in the Development of New Antiretroviral Drugs for the Treatment of HIV/AIDS
Heera Jayvant R, van der Ryst Elna
Drug Development , 2009
Endogenous Stem Cell Activation in the Brain
Activation of Endogenous Stem Cells in the Brain – A Novel Approach to Central Nervous System Disease
Wikström Lilian
Drug Discovery, 2009
Nasal Polyposis Treatment
Latest Articles
Drug Discovery, 2010
Drug Development , 2009
Drug Discovery, 2009








